Source: Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016



Rating:

Share or cite this content

Citations should be made in the following way:
Francesco Dentali, Nicola Mumoli, Andrea Fontanella, Matteo Nicola Dario Di Minno. Efficacy and safety of extended antithrombotic prophylaxis in elderly medically ill patients. Eur Respir J 2017; 49(1): 1601887; DOI: 10.1183/13993003.01887-2016

Member's Comments

No comment yet.

Related content which might interest you: Clinical efficacy of moxifloxacin in severely ill patients with CAP Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Iloprost delivery and efficacy in critically ill patients Source: Annual Congress 2007 - Problems in intensive care medicine Year: 2007 Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Steroid use in elderly critically ill COVID-19 patients Source: Eur Respir J, 58 (4) 2100979; 10.1183/13993003.00979-2021 Year: 2021 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Evaluation of efficacy and safety of budesonide/formeterol combination therapy in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006 The efficacy and safety of stereotactic radiation therapy for elderly patients Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Sticker reminders improve VTE prophylaxis appropriatness in hospitalized patients Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 Efficacy and safety of bronchoscopy in the elderly Source: Eur Respir J 2004; 24: Suppl. 48, 70s Year: 2004 The effectiveness and safety of pre-hospital nebulizer therapy of elderly patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002 Efficacy and safety of nintedanib in the elderly patient with IPF Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures Source: Eur Respir Rev, 26 (145) 170020; 10.1183/16000617.0020-2017 Year: 2017 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019 Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019 Safety profile of tiotropium add-on therapy in paediatric patients by gender Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Efficacy and safety of stepwise therapy in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients Source: Eur Respir J 2004; 24: Suppl. 48, 273s Year: 2004 Efficacy and safety of chemotherapy regimens containing fluoroquinolones in pediatric TB Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea Source: International Congress 2016 – Acute pulmonary embolism Year: 2016